HUNTINGTON MEDICAL RESEARCH INSTITUTES
Balance Sheet
Fiscal Year Start:
Oct 1
Assets in 2024 (Year End)
$64,324,194
Property, Plant, & Equipment (net)
46%
Investments
34%
Cash & Equivalents
16%
Receivables (Non-Related)
3%
Other Assets
<1%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$2,074,994
Other Liabilities
52%
Payables & Accruals
47%
Deferred Revenue
<1%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$3,738,954
$10,608,446
+184%
Receivables (Non-Related)
$3,045,623
$1,833,103
-40%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$174,000
$79,452
-54%
Investments
$28,414,993
$21,911,049
-23%
Property, Plant, & Equipment (net)
$30,810,177
$29,645,236
-4%
Other Assets
$165,375
$246,908
+49%
Total Assets
$66,349,122
$64,324,194
-3%
Liabilities
2023
2024
Change
Payables & Accruals
$802,875
$971,978
+21%
Grants Payable
-
-
-
Deferred Revenue
$0
$17,300
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$1,317,307
$1,085,716
-18%
Total Liabilities
$2,120,182
$2,074,994
-2%
Net assets
2023
2024
Change
Restricted Net Assets
$21,528,806
$17,394,060
-19%
Unrestricted Net Assets
$42,700,134
$44,855,140
+5%
Net assets
2023
2024
Change
Net assets
+$64,228,940
+$62,249,200
-3%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)